UH-232UH-232, or (+)-UH-232, also known as 5-hydroxy-1-methyl-2-(dipropylamino)tetralin methyl ether (5-HMDPTME), is a dopamine and serotonin receptor modulator of the 2-aminotetralin family which was under development for the treatment of schizophrenia but was never marketed. Read from the Drugbox of the Wikipedia article UH-232, revision 1379545036.

Property

Value

Formula

C18H29NO, 275.43 g/mol

Bioavailability

3.7 %

Elimination half-life

2.5 h

The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.